BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30117263)

  • 21. The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.
    Kulkarni H; Marconi VC; He W; Landrum ML; Okulicz JF; Delmar J; Kazandjian D; Castiblanco J; Ahuja SS; Wright EJ; Weiss RA; Clark RA; Dolan MJ; Ahuja SK
    Blood; 2009 Sep; 114(13):2783-92. PubMed ID: 19620399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign familial leukopenia and neutropenia in different ethnic groups.
    Shoenfeld Y; Alkan ML; Asaly A; Carmeli Y; Katz M
    Eur J Haematol; 1988 Sep; 41(3):273-7. PubMed ID: 3181399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute neutrophil count by Duffy status among healthy Black and African American adults.
    Merz LE; Story CM; Osei MA; Jolley K; Ren S; Park HS; Yefidoff Freedman R; Neuberg D; Smeland-Wagman R; Kaufman RM; Achebe MO
    Blood Adv; 2023 Feb; 7(3):317-320. PubMed ID: 35994632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between a Common, Benign Genotype and Unnecessary Bone Marrow Biopsies Among African American Patients.
    Van Driest SL; Abul-Husn NS; Glessner JT; Bastarache L; Nirenberg S; Schildcrout JS; Eswarappa MS; Belbin GM; Shaffer CM; Mentch F; Connolly J; Shi M; Stein CM; Roden DM; Hakonarson H; Cox NJ; Borinstein SC; Mosley JD
    JAMA Intern Med; 2021 Aug; 181(8):1100-1105. PubMed ID: 34180972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis.
    Duchene J; Novitzky-Basso I; Thiriot A; Casanova-Acebes M; Bianchini M; Etheridge SL; Hub E; Nitz K; Artinger K; Eller K; Caamaño J; Rülicke T; Moss P; Megens RTA; von Andrian UH; Hidalgo A; Weber C; Rot A
    Nat Immunol; 2017 Jul; 18(7):753-761. PubMed ID: 28553950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duffy-negative is associated with hemolytic phenotype of sickle cell anemia.
    Mecabo G; Hayashida DY; Azevedo-Shimmoto MM; Vicari P; Arruda MM; Bordin JO; Figueiredo MS
    Clin Immunol; 2010 Sep; 136(3):458-9; author reply 460-1. PubMed ID: 20638342
    [No Abstract]   [Full Text] [Related]  

  • 27. When non-Whiteness becomes a condition.
    Merz LE; Achebe M
    Blood; 2021 Jan; 137(1):13-15. PubMed ID: 33181819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-onset neutropenia in very low birth weight infants.
    Omar SA; Salhadar A; Wooliever DE; Alsgaard PK
    Pediatrics; 2000 Oct; 106(4):E55. PubMed ID: 11015550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Clinical Characterization of Children With Benign Ethnic Neutropenia.
    Ortiz MV; Meier ER; Hsieh MM
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e140-3. PubMed ID: 26925714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients.
    Nebor D; Durpes MC; Mougenel D; Mukisi-Mukaza M; Elion J; Hardy-Dessources MD; Romana M
    Clin Immunol; 2010 Jul; 136(1):116-22. PubMed ID: 20347396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of circadian variation on neutrophil mobilization to the peripheral blood in benign constitutional neutropenia.
    Souto Filho JTD; Portugal RD; Nucci M
    Exp Hematol; 2019 Jan; 69():22-26. PubMed ID: 30367920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the Duffy antigen receptor for chemokines (DARC) expression and clinical outcome of children with sickle cell anemia.
    Araujo NB; Domingos IF; Medeiros FS; Hatzlhofer BL; Mendonça TF; Vasconcelos LR; Cavalcanti Mdo S; Araujo AS; Oliveira Mdo C; Lucena-Araujo AR; Bezerra MA
    Immunol Lett; 2015 Aug; 166(2):140-2. PubMed ID: 26045319
    [No Abstract]   [Full Text] [Related]  

  • 34. A structural model of a seven-transmembrane helix receptor: the Duffy antigen/receptor for chemokine (DARC).
    de Brevern AG; Wong H; Tournamille C; Colin Y; Le Van Kim C; Etchebest C
    Biochim Biophys Acta; 2005 Aug; 1724(3):288-306. PubMed ID: 16046070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte response to administration of corticosteroid in healthy black children with neutropenia.
    Haddy TB; Rana SR
    J Pediatr; 1994 May; 124(5 Pt 1):739-41. PubMed ID: 8176562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
    Peiper SC; Wang ZX; Neote K; Martin AW; Showell HJ; Conklyn MJ; Ogborne K; Hadley TJ; Lu ZH; Hesselgesser J; Horuk R
    J Exp Med; 1995 Apr; 181(4):1311-7. PubMed ID: 7699323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of Duffy antigen to chemokine function.
    Rot A
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):687-94. PubMed ID: 16054417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
    Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
    PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count.
    El-Beshlawy AM; El-Alfy MS; Sari TT; Chan LL; Tricta F
    Eur J Haematol; 2014 Apr; 92(4):337-40. PubMed ID: 24330079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer.
    Latini FR; Bastos AU; Arnoni CP; Muniz JG; Person RM; Baleotti W; Barreto JA; Castilho L; Cerutti JM
    Blood Cells Mol Dis; 2013 Mar; 50(3):161-5. PubMed ID: 23168236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.